HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Hoey Investments Inc.

Hoey Investments Inc. lessened its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,843 shares of the company's stock after selling 759 shares during the quarter. Hoey Investments Inc.'s holdings in HCA Healthcare were worth $853,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Congress Wealth Management LLC DE raised its position in HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the period. Evergreen Private Wealth LLC lifted its stake in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after purchasing an additional 35 shares during the last quarter. Mediolanum International Funds Ltd raised its holdings in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after buying an additional 36 shares during the period. Prairie Wealth Advisors Inc. boosted its holdings in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after acquiring an additional 40 shares during the period. Finally, Whittier Trust Co. lifted its position in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after purchasing an additional 41 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

HCA Healthcare Price Performance

Shares of HCA stock traded up $1.75 during mid-day trading on Wednesday, hitting $347.48. 1,249,318 shares of the stock were exchanged, compared to its average volume of 1,347,916. The company has a market cap of $85.55 billion, a PE ratio of 15.82, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a fifty day moving average of $325.79 and a 200 day moving average of $340.25.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.83%. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's dividend payout ratio is presently 13.11%.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Finally, Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.